Sinopharm
1099.HK
#1992
Rank
ยฃ6.60 B
Marketcap
ยฃ2.12
Share price
0.24%
Change (1 day)
1.87%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): ยฃ2.01 Billion

According to Sinopharm's latest financial reports the company's current earnings are ยฃ80.05 Billion. In 2022 the company made an earning of ยฃ2.56 Billion a decrease over its 2021 earnings that were of ยฃ2.61 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) ยฃ2.01 B-21.38%
2022 ยฃ2.56 B-1.72%
2021ยฃ2.61 B11.7%
2020ยฃ2.33 B18.44%
2019ยฃ1.97 B10.85%
2018ยฃ1.78 B3.05%
2017ยฃ1.72 B36.48%
2016ยฃ1.26 B7.11%
2015ยฃ1.18 B12.38%
2014ยฃ1.05 B25.05%
2013ยฃ0.84 B22.54%
2012ยฃ0.68 B35.43%
2011ยฃ0.50 B52.24%
2010ยฃ0.33 B30.99%
2009ยฃ0.25 B60.59%
2008ยฃ0.15 B48.29%
2007ยฃ0.10 B123.29%
2006ยฃ47.82 M